Phase II trial of hypofractionated VMAT-based treatment for early stage breast cancer: 2-year toxicity and clinical results
Crossref DOI link: https://doi.org/10.1186/s13014-016-0701-z
Published Online: 2016-09-17
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
De Rose, Fiorenza
Fogliata, Antonella
Franceschini, Davide
Navarria, Piera
Villa, Elisa
Iftode, Cristina
D’Agostino, Giuseppe
Cozzi, Luca
Lobefalo, Francesca
Mancosu, Pietro
Tomatis, Stefano
Scorsetti, Marta